In a sign that researchers are grappling with therapy development, the 4th International Conference on Clinical Trials on Alzheimer's Disease was filled beyond the capacity of its venue, drawing 522 researchers from around the globe. Held 3-5 November 2011 in San Diego, CTAD is the brainchild of Paul Aisen, Jacques Touchon, Bruno Vellas, and Michael Weiner.
The conference posted no ringing trial successes; instead, scientists worked on methodological aspects they hope will improve future trials’ chances. Setting the stage for this work was Paul Aisen’s keynote address spanning a historical arc of when and how therapeutic trials in AD started, how they got stuck in the current trough of negative results, and how he believes they might move forward again. Alzforum asked Aisen to give his lecture a second time on our Webinar platform to share it with the wider global research community. For more background, see ARF related conference story. The Webinar recording below anchored Alzforum’s CTAD 2011 coverage. Play the recording, and share your questions and comments about it in the comment box below.
The Alzheimer Disease Early Detection Surveys were designed to gauge perceptions and knowledge of early detection of Alzheimer disease as a follow-up to our Early Detection Webinar. The surveys were developed in collaboration with the Geoffrey Beene Foundation.
View Researcher Survey Results [.pdf].
View Public Survey Results [.pdf].
The AlzPossible Initiative is
an innovative "center without walls" that enables skilled individuals to share their knowledge about best practices in Alzheimer caregiving through this open forum.